Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the ProteasomeSusan D. Demo, Mark K. Bennett|Cancer Research|2007Cited by 671
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibitionNathalie Jacque, Didier Bouscary, Clément Larrue et al.|Blood|2015Cited by 383